Former Centers for Disease Control and Prevention Director Dr. Robert Redfield appeared Wednesday on Newsmax to discuss Dr.

Matthew B. Oppenheimer, the Chief Executive Officer of Remitly Global , Inc. (NASDAQ:RELY), recently sold a significant ...

Fintel reports that on January 24, 2025, Oppenheimer downgraded their outlook for Exelixis (NasdaqGS:EXEL) from Outperform to ...

The card collecting industry has exploded in recent years to such an extent that industry leader Topps is now producing a Robert Oppenheimer card that's ...

Toast (TOST) shares gained 1.5% in Friday premarket trading after Oppenheimer started coverage on the stock with an ...

(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...

SentinelOne Inc (S) stock saw a modest uptick, ending the day at $23.22 which represents a slight increase of $0.49 or 2.16% from the prior close of $22.73. The stock opened at $23 and touched a low ...

The smartest investment move for 2025 might be the simplest: staying invested for the long term. Market fears around politics, inflation, and high valuations rarely predict long-term returns.

Oppenheimer analysts updated their “buy” and “sell” recommendations within each of the 11 sectors among small- and mid-caps. According to Investors Intelligence’s bull/bear metric ...

Oppenheimer has chosen its top stock picks for 2025 while the semiconductor sector gets up for a crucial earnings season.

Jamie Foxx recently joined Vanity Fair for a video interview in which he looked back at a handful of his most iconic acting roles, including the title character in Quentin Tarantino’s “Django ...

R Madhavan expressed disappointment with Hollywood, criticizing Christopher Nolan's 'Oppenheimer' for lacking emotional depth ...